Department of Molecular and Human Genetics, Baylor College of Medicine , Houston, TX, USA.
Department of Pediatrics, Baylor College of Medicine , Houston, TX, USA.
Expert Rev Mol Diagn. 2020 Oct;20(10):995-1002. doi: 10.1080/14737159.2020.1826312. Epub 2020 Oct 10.
The human genome contains the instructions for the development and biological homeostasis of the human organism and the genetic transmission of traits. Genome variation in human populations is the basis of evolution; individual or personal genomes vary tremendously, making each of us truly unique.
Assaying this individual variation using genomic technologies has many applications in clinical medicine, from elucidating the biology of disease to designing strategies to ameliorate perturbations from homeostasis. Detecting pathogenic rare variation in a genome may provide a molecular diagnosis that can be informative for patient management and family healthcare.
Despite the increasing clinical use of unbiased genomic testing, including chromosome microarray analysis (CMA) with array comparative genomic hybridization (aCGH) or SNP arrays, clinical exome sequencing (cES), and whole-genome sequencing (WGS), to survey genome-wide for molecular aberrations, clinical acumen paired with an understanding of the limitations of each testing type will be needed to achieve molecular diagnoses. Potential opportunities for improving case solved rates, functionally annotating the majority of genes in the human genome, and further understanding genetic contributions to disease will empower clinical genomics and the precision medicine initiative.
人类基因组包含了人类机体发育和生物内稳态的指令以及特征的遗传传递。人类群体中的基因组变异是进化的基础;个体或个人基因组差异巨大,使我们每个人都独一无二。
使用基因组技术检测这种个体变异在临床医学中有许多应用,从阐明疾病的生物学机制到设计策略来改善内稳态的干扰。在基因组中检测致病性罕见变异可以提供分子诊断,这对患者管理和家庭保健具有信息意义。
尽管越来越多的临床应用了无偏基因组测试,包括染色体微阵列分析(CMA)与 array 比较基因组杂交(aCGH)或 SNP 阵列、临床外显子组测序(cES)和全基因组测序(WGS),以全面调查基因组中的分子异常,但临床敏锐度与对每种测试类型的局限性的理解相结合,将需要实现分子诊断。提高病例解决率、对人类基因组中的大多数基因进行功能注释以及进一步了解遗传对疾病的贡献的潜在机会,将赋予临床基因组学和精准医疗计划权力。